Last reviewed · How we verify
Monoclonal Antibody J591
Monoclonal Antibody J591 is a Small molecule drug developed by BZL Biologics. It is currently in Phase 2 development.
At a glance
| Generic name | Monoclonal Antibody J591 |
|---|---|
| Sponsor | BZL Biologics |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC (PHASE1, PHASE2)
- Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer (PHASE1, PHASE2)
- TmPSMA-02 in mCRPC (PHASE1)
- Re-treatment 225Ac-J591 for mCRPC (EARLY_PHASE1)
- Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer (PHASE1, PHASE2)
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer (PHASE2)
- Phase I Trial of 225Ac-J591 in Patients With mCRPC (PHASE1)
- ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Monoclonal Antibody J591 CI brief — competitive landscape report
- Monoclonal Antibody J591 updates RSS · CI watch RSS
- BZL Biologics portfolio CI
Frequently asked questions about Monoclonal Antibody J591
What is Monoclonal Antibody J591?
Monoclonal Antibody J591 is a Small molecule drug developed by BZL Biologics.
Who makes Monoclonal Antibody J591?
Monoclonal Antibody J591 is developed by BZL Biologics (see full BZL Biologics pipeline at /company/bzl-biologics).
What development phase is Monoclonal Antibody J591 in?
Monoclonal Antibody J591 is in Phase 2.
Related
- Manufacturer: BZL Biologics — full pipeline
- Compare: Monoclonal Antibody J591 vs similar drugs
- Pricing: Monoclonal Antibody J591 cost, discount & access